Global Fusion Biopsy Market Overview:
Global Fusion Biopsy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Fusion Biopsy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Fusion Biopsy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Fusion Biopsy Market:
The Fusion Biopsy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Fusion Biopsy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Fusion Biopsy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Fusion Biopsy market has been segmented into:
DNA
RNA
Protein
By Application, Fusion Biopsy market has been segmented into:
Multi-gene Panels
Single-gene Tests
Companion Diagnostics
Research Use Only (RUO
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Fusion Biopsy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Fusion Biopsy market.
Top Key Players Covered in Fusion Biopsy market are:
Hologic Inc
Exact Sciences Corporation
Myriad Genetics Inc
BioRad Laboratories Inc
Invivoscribe
Leica Biosystems
Affymetrix Inc
QIAGEN N.V.
BD (Becton
Dickinson and Company)
Agilent Technologies Inc
Genomic Health
Sysmex Corporation
Beckman Coulter Inc
Thermo Fisher Scientific Inc.
Illumina Inc
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Fusion Biopsy Market Type
4.1 Fusion Biopsy Market Snapshot and Growth Engine
4.2 Fusion Biopsy Market Overview
4.3 DNA
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 DNA: Geographic Segmentation Analysis
4.4 RNA
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 RNA: Geographic Segmentation Analysis
4.5 Protein
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Protein: Geographic Segmentation Analysis
Chapter 5: Fusion Biopsy Market Application
5.1 Fusion Biopsy Market Snapshot and Growth Engine
5.2 Fusion Biopsy Market Overview
5.3 Multi-gene Panels
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Multi-gene Panels: Geographic Segmentation Analysis
5.4 Single-gene Tests
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Single-gene Tests: Geographic Segmentation Analysis
5.5 Companion Diagnostics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Companion Diagnostics: Geographic Segmentation Analysis
5.6 Research Use Only (RUO
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Research Use Only (RUO: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Fusion Biopsy Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 HOLOGIC INC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 EXACT SCIENCES CORPORATION
6.4 MYRIAD GENETICS INC
6.5 BIORAD LABORATORIES INC
6.6 INVIVOSCRIBE
6.7 LEICA BIOSYSTEMS
6.8 AFFYMETRIX INC
6.9 QIAGEN N.V.
6.10 BD (BECTON
6.11 DICKINSON AND COMPANY)
6.12 AGILENT TECHNOLOGIES INC
6.13 GENOMIC HEALTH
6.14 SYSMEX CORPORATION
6.15 BECKMAN COULTER INC
6.16 THERMO FISHER SCIENTIFIC INC.
6.17 ILLUMINA INC
Chapter 7: Global Fusion Biopsy Market By Region
7.1 Overview
7.2. North America Fusion Biopsy Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 DNA
7.2.2.2 RNA
7.2.2.3 Protein
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Multi-gene Panels
7.2.3.2 Single-gene Tests
7.2.3.3 Companion Diagnostics
7.2.3.4 Research Use Only (RUO
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Fusion Biopsy Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 DNA
7.3.2.2 RNA
7.3.2.3 Protein
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Multi-gene Panels
7.3.3.2 Single-gene Tests
7.3.3.3 Companion Diagnostics
7.3.3.4 Research Use Only (RUO
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Fusion Biopsy Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 DNA
7.4.2.2 RNA
7.4.2.3 Protein
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Multi-gene Panels
7.4.3.2 Single-gene Tests
7.4.3.3 Companion Diagnostics
7.4.3.4 Research Use Only (RUO
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Fusion Biopsy Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 DNA
7.5.2.2 RNA
7.5.2.3 Protein
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Multi-gene Panels
7.5.3.2 Single-gene Tests
7.5.3.3 Companion Diagnostics
7.5.3.4 Research Use Only (RUO
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Fusion Biopsy Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 DNA
7.6.2.2 RNA
7.6.2.3 Protein
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Multi-gene Panels
7.6.3.2 Single-gene Tests
7.6.3.3 Companion Diagnostics
7.6.3.4 Research Use Only (RUO
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Fusion Biopsy Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 DNA
7.7.2.2 RNA
7.7.2.3 Protein
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Multi-gene Panels
7.7.3.2 Single-gene Tests
7.7.3.3 Companion Diagnostics
7.7.3.4 Research Use Only (RUO
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Fusion Biopsy Scope:
|
Report Data
|
Fusion Biopsy Market
|
|
Fusion Biopsy Market Size in 2025
|
USD XX million
|
|
Fusion Biopsy CAGR 2025 - 2032
|
XX%
|
|
Fusion Biopsy Base Year
|
2024
|
|
Fusion Biopsy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Hologic Inc, Exact Sciences Corporation, Myriad Genetics Inc, BioRad Laboratories Inc, Invivoscribe, Leica Biosystems, Affymetrix Inc, QIAGEN N.V., BD (Becton, Dickinson and Company), Agilent Technologies Inc, Genomic Health, Sysmex Corporation, Beckman Coulter Inc, Thermo Fisher Scientific Inc., Illumina Inc.
|
|
Key Segments
|
By Type
DNA
RNA
Protein
By Applications
Multi-gene Panels
Single-gene Tests
Companion Diagnostics
Research Use Only (RUO
|
